• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Bone Graft Substitutes Market

    ID: MRFR/HC/0689-CR
    143 Pages
    Rahul Gotadki
    April 2025

    Bone Graft Substitute Market Research Report Information, By Type (Allograft, Bone Graft Substitute, And Cell-Based Matrices), By Application (Dental, Foot & Ankle, Joint Reconstruction, Long Bone, Spinal Fusion, And Others), By Region (Americas, Europe, Asia-Pacific, And Middle East & Africa) –Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Bone Graft Substitutes Market Infographic
    Purchase Options

    Bone Graft Substitutes Market Summary

    As per Market Research Future Analysis, the Bone Graft Substitute Market was valued at USD 3.67 billion in 2024 and is projected to grow to USD 7.83 billion by 2035, with a CAGR of 6.52% from 2025 to 2035. The market growth is driven by the increasing incidence of road injuries and joint disorders, alongside advancements in biocompatible synthetic bone grafts. The allograft segment is the largest and fastest-growing segment, while spinal fusion is the leading application area. The Americas held the largest market share in 2023, with North America being the dominant region due to high orthopedic surgery volumes and a robust healthcare infrastructure.

    Key Market Trends & Highlights

    Key trends driving the Bone Graft Substitute Market include rising injury rates and technological advancements.

    • Projected market growth from USD 3.91 billion in 2025 to USD 7.83 billion by 2035.
    • Allograft segment dominated the market in 2023 and is expected to grow rapidly.
    • Spinal fusion segment projected to be the fastest-growing application area.
    • 93% of road fatalities occur in low- and middle-income countries, highlighting the need for effective bone grafting solutions.

    Market Size & Forecast

    2024 Market Size USD 3.67 Billion
    2035 Market Size USD 7.83 Billion
    CAGR (2025-2035) 6.52%

    Major Players

    Johnson & Johnson Inc. (US), Baxter (US), Integra Lifesciences Holdings Corporation (US), Orthox Medical Inc. (US), Geistlich Pharma AG (Switzerland), Medtronic (Ireland), AlloSource (Colorado), Zimmer Biomet (US), Stryker (US), Smith & Nephew (US)

    Bone Graft Substitutes Market Trends

    Rising incidence of road injuries and joint disorders

    Bone grafting is a surgical technique used to fix problems by using transplanted bone to repair, rebuild, and replace missing bones and reconstructing joint disorders. It is possible because bone tissue can regenerate completely once the space is provided into which it has to grow as natural bone.

    The rate of road injuries is on the rise. For instance, according to the Sustainable Transport Conference 2021, boys and men account for 75% of road fatalities, highlighting a significant gender disparity in traffic-related deaths. Additionally, between 20 and 50 million people suffer non-fatal injuries each year due to road traffic crashes. Alarmingly, 93% of the world's road fatalities occur in low- and middle-income countries, despite these nations having only about 60% of the world's vehicles.

    Furthermore, the death rate from road crashes in low-income countries is more than 3.5 times higher than in high-income countries, underscoring the disproportionate impact of road traffic accidents in these regions.

    Bone grafting has numerous applications in fixing injuries and diseases. It may be used in the case of multiple or complex fractures or those that do not heal well after initial treatment. It is also used for fusion which helps two bones heal across a diseased joint. Fusion is most often done on the spine. Regeneration is used for bone lost to disease, infection, or injury. 

    This can involve using small amounts of bone in bone cavities or large sections of bones and a graft can be used to help bone heal around surgically implanted devices, like Artificil joint replacements, plates, or screws. Hence, with all these applications, bone grafting poses is an effective technique to treat road injuries and joint disorders.

    Bone Graft Substitute Market 

    The Global Bone Graft Substitute Market is poised for expansion, driven by advancements in biomaterials and an increasing prevalence of orthopedic conditions that necessitate innovative surgical interventions.

    U.S. Department of Health and Human Services

    Bone Graft Substitutes Market Drivers

    Market Growth Projections

    The Global Bone Graft Substitute Market Industry is poised for substantial growth, with projections indicating a market value of 3.67 USD Billion in 2024 and an anticipated increase to 7.83 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 7.13% from 2025 to 2035, highlighting the increasing demand for innovative solutions in orthopedic treatments. The market's expansion is driven by various factors, including technological advancements, rising prevalence of bone disorders, and a shift towards minimally invasive procedures. These dynamics collectively contribute to a promising outlook for the industry.

    Growing Awareness and Education

    Increasing awareness and education regarding bone health and treatment options are crucial for the Global Bone Graft Substitute Market Industry. Healthcare professionals and patients alike are becoming more informed about the benefits of bone graft substitutes, leading to higher adoption rates. Educational campaigns and professional training programs emphasize the importance of timely intervention for bone disorders, which in turn drives demand for effective substitutes. As awareness continues to grow, the market is expected to experience sustained growth, reflecting the evolving landscape of orthopedic care.

    Government Initiatives and Funding

    Government initiatives aimed at improving healthcare infrastructure and funding for orthopedic research are vital drivers of the Global Bone Graft Substitute Market Industry. Various countries are investing in healthcare advancements, including the development of innovative bone graft substitutes. For instance, funding programs that support research into new biomaterials and surgical techniques are likely to enhance the availability and effectiveness of these products. Such initiatives not only stimulate market growth but also ensure that patients have access to the latest treatment options, fostering a more robust healthcare environment.

    Increasing Prevalence of Bone Disorders

    The rising incidence of bone disorders, including osteoporosis and fractures, is a primary driver for the Global Bone Graft Substitute Market Industry. As populations age, the demand for effective treatment options escalates. For instance, osteoporosis affects millions globally, leading to a significant number of fractures annually. This trend necessitates innovative solutions like bone graft substitutes, which are increasingly favored for their efficacy in promoting bone healing. The market is projected to reach 3.67 USD Billion in 2024, reflecting the urgent need for advanced treatment modalities in orthopedic surgeries.

    Rising Demand for Minimally Invasive Procedures

    The growing preference for minimally invasive surgical techniques is influencing the Global Bone Graft Substitute Market Industry. Patients increasingly seek procedures that reduce recovery time and minimize complications. Bone graft substitutes align well with these preferences, as they can be utilized in less invasive surgeries, thereby enhancing patient satisfaction. The market's expansion is evident, with projections indicating it could reach 7.83 USD Billion by 2035. This shift towards less invasive options underscores the importance of bone graft substitutes in modern surgical practices.

    Technological Advancements in Bone Graft Substitutes

    Technological innovations in the development of bone graft substitutes are propelling the Global Bone Graft Substitute Market Industry forward. New materials and techniques, such as bioactive ceramics and synthetic polymers, enhance the effectiveness of these substitutes. For example, advancements in 3D printing technology allow for customized grafts tailored to individual patient needs, improving surgical outcomes. This continuous evolution in product offerings is expected to contribute to a compound annual growth rate of 7.13% from 2025 to 2035, indicating a robust market trajectory driven by innovation.

    Market Segment Insights

    Bone Graft Substitute Application Insights

    Applications of bone graft substitutes are increasing rapidly as other bone graft types such as autografts and allografts have disadvantages, such as limited availability, site morbidity and pain, and prone to infections. In fact, DBM are used in 50% of allografts performed in the US. The Bone Graft Substitute Market , by application, is segmented into dental, foot & ankle, joint reconstruction, long bone, and spinal fusion. The spinal fusion segment dominated the market in 2020. The spinal fusion segment is projected to be the fastest-growing segment during the study period.

    Spinal fusion is an extremely important procedure wherein a solid bridge is formed between two vertebral of the spines to stop the movement in that section. It is very important to understand that bone grafts do not directly heal the spinal distress or carry out the spinal fusion. However, bone graft creates an environment for that solid bridge to form. Bone graft provides a foundation for the spine and allows the body to regenerate the bone and fuse the section of the spine. They provide stability to the spine while the body heals itself.

    Get more detailed insights about Bone Graft Substitute Market Research Report-Forecast till 2035

    Regional Insights

    On the basis of region, the Bone Graft Substitute Market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Americas held the largest market in 2023, and Asia-Pacific is accounted for the fastest growing region during the forecast period.

    The Americas is further segmented into North America and Latin America. North America accounted for a largest market in 2023, and expected to show steady growth. The North American market is further divided into the US and Canada. The largest market share of 81.0% of North Americas is due to several factors such as high volumes of orthopedic surgeries, adoption of bone graft substitutes, and the presence of prominent key players.

    In addition, the presence of major market players in this region involved in product innovation expansion, expansion, and strategic collaborations, and well-developed healthcare infrastructure are contributing towards the market growth. For instance, in February 2019, Medtronic plc announced approval and launch of Japan's first Grafton Demineralized Bone Matrix (DBM) bone grafting product for spine and orthopedic procedures.

    Figure 3: Bone Graft Substitute Market BY REGION 2024 & 2035 (USD Billion)

    BONE GRAFT SUBSTITUTE MARKET BY REGION 2024 & 2035

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Key Players and Competitive Insights

    The Bone Graft Substitute Market is distinguished by the presence of numerous regional and local players catering to the Bone Graft Substitute Market. Furthermore, the rising incidence of road injuries and joint disorders and development of biocompatible synthetic bone grafts are driving the Bone Graft Substitute Market .

    The Bone Graft Substitute Market is extremely competitive, with players competing and investing heavily in the development of innovative products to gain a significant market share. The market is highly fragmented with high competition in the market, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.

    The growth of prominent industry players is dependent on various factors, such as market conditions, product differentiation and innovation, and pricing strategies. It is also projected that upsurge in demand for orthopedic procedures among geriatric population and high investment in orthopedic care sector will boost the market's growth in the upcoming future.

    Key Companies in the Bone Graft Substitutes Market market include

    Industry Developments

    December 2024: Zimmer Biomet Holdings, Inc. received U.S. Food and Drug Administration (FDA) clearance for the OsseoFit Stemless Shoulder System for total shoulder replacement. This innovative implant is designed to match the natural humeral (upper shoulder bone) anatomy1-3 to optimize anatomical fit while maximizing preservation of healthy bone.

    May 2024: Medtronic received FDA approval for the Infuse bone transplant, which includes an intervertebral fusion device and a commercially available metallic screw and rod system. This designation refers to the use of Infuse bone graft in a transforaminal lumbar interbody fusion (TLIF) surgical procedure at one or two adjacent levels from L2 to S1 in the treatment of degenerative disorders of the lumbosacral spine.

    November 2023: Smith+Nephew has signed a definitive agreement to buy CartiHeal, the developer of Agili-C, a revolutionary sports medicine technology for knee cartilage regeneration. Under the terms of the agreement, Smith+Nephew will pay an initial cash consideration of $180 million at closing, with an additional $150 million based on financial performance.

    March 2022: Biocomposites entered into partnership with Zimmer Biomet, a global medical technology leader, to exclusively supply genex Bone Graft Substitute with its novel mixing system and delivery options in the US orthopaedic market.

    Future Outlook

    Bone Graft Substitutes Market Future Outlook

    The Bone Graft Substitute Market is projected to grow at a 7.13% CAGR from 2024 to 2035, driven by technological advancements, increasing orthopedic procedures, and rising geriatric populations.

    New opportunities lie in:

    • Develop bioactive materials to enhance healing rates in bone grafts. Expand product lines to include minimally invasive surgical options. Leverage digital marketing strategies to reach orthopedic surgeons effectively.

    By 2035, the Bone Graft Substitute Market is expected to exhibit robust growth, reflecting advancements and increased adoption.

    Market Segmentation

    Form Outlook

    • Spinal Fusion
    • Joint Reconstruction
    • Long Bone
    • Dental
    • Foot & Ankle
    • Others

    Type Outlook

    • Allograft
    • Bone Graft Substitute
    • Cell-Based Matrices

    Regional Outlook

    • North America
    • US
    • Canada
    • Latin America
    • Western Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Western Europe
    • Eastern Europe
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Middle East
    • Africa

    Bone Graft Substitute Form Outlook

    • Spinal Fusion
    • Joint Reconstruction
    • Long Bone
    • Dental
    • Foot & Ankle
    • Others

    Bone Graft Substitute Type Outlook

    • Allograft
    • Bone Graft Substitute
    • Cell-Based Matrices

    Bone Graft Substitute Regional Outlook

    • North America
    • US
    • Canada
    • Latin America
    • Western Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Western Europe
    • Eastern Europe
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Middle East
    • Africa

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2024USD 3.67 billion
    Market Size 2025USD 3.91 billion
    Market Size 2035USD 7.83 billion
    Compound Annual Growth Rate (CAGR)6.52% (2025-2035)
    Base Year2024
    Forecast Period2025-2035
    Historical Data2019 - 2023
    Forecast UnitsValue (USD Billion)
    Report CoverageRevenue Forecast, Market Competitive Landscape, Growth Factors, and Trends.
    Segments CoveredType, Application and Region
    Key Companies ProfiledJohnson & Johnson Inc. (US), Baxter (US), Integra Lifesciences Holdings Corporation (US), Orthox Medical Inc. (US), Geistlich Pharma AG (Switzerland), Medtronic (Ireland), AlloSource (Colorado), Zimmer Biomet (US), Stryker (US), Smith & Nephew (US)
    Key Market Opportunities·         High investment in orthopedic care sector   ·         Upsurge in demand for orthopedic procedures among geriatric population
    Key Market Dynamics·         Rising incidence of road injuries and joint disorders   ·         Development of biocompatible synthetic bone grafts     

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How much is the Bone Graft Substitute Market ?

    The Bone Graft Substitute Market is anticipated to reach 7.83 billion at a CAGR of 6.52% during the forecast period of 2024-2035.

    What is the growth rate of the Bone Graft Substitute Market ?

    The Bone Graft Substitute Market is expected to grow at a 6.52% CAGR during the forecast period from 2025 to 2035.

    Which region held the largest market share in 2024 in the Bone Graft Substitute Market ?

    The North America region market is estimated to hold the largest market share in the Bone Graft Substitute Market .

    Who are the key players in the Bone Graft Substitute Market ?

    The key players include Johnson & Johnson Inc. (US), Baxter (US), Integra Lifesciences Holdings Corporation (US), Orthox Medical Inc. (US), Geistlich Pharma AG (Switzerland), Medtronic (Ireland), AlloSource (Colorado), Zimmer Biomet (US), Stryker (US), Smith & Nephew (US).

    Which Type segment led the Bone Graft Substitute Market in 2024?

    Allografts segment dominated the market in 2024.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials